• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Hesterbio Share Price

    Hester Biosciences Share PriceHester Biosciences

    Small Cap 3.4k Result
    ₹1523.65
    -12.6 (-0.82%)
    As on 29 November, 2023 | 02:22 BSE: 524669 NSE: HESTERBIOISIN: INE782E01017

    Hester Biosciences Performance

    Day Range

    • Low 1518.1
    • High 1540
    1523.65

    52 Week Range

    • Low 1404.55
    • High 2015
    1523.65
    • Open Price1540
    • Previous Close1540
    • Volume3310

    Start SIP in Hester Biosciences

    Start SIP

    Hester Biosciences Share Price

    • Over 1 Month -7.63%
    • Over 3 Month -10.45%
    • Over 6 Month -8.04%
    • Over 1 Year -20.97%

    Hester Biosciences Key Statistics

    P/E Ratio 50.5
    PEG Ratio -9.5
    Market Cap Cr 1,296
    Price to Book Ratio 4.5
    EPS 38
    Dividend 0.5
    Relative Strength Index 32.04
    Money Flow Index 25.55
    MACD Signal -32.12
    Average True Range 37.08

    Hester Biosciences Investment Rating

    • Master Rating:

    • Hester Biosciences has an operating revenue of Rs. 300.55 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 13% is healthy, ROE of 9% is fair but needs improvement. The company has a debt to equity of 66%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 8 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 117 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Hester Biosciences Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 66806171725150
    Operating Expenses Qtr Cr 54695052564140
    Operating Profit Qtr Cr 1211111916910
    Depreciation Qtr Cr 3332223
    Interest Qtr Cr 1103211
    Tax Qtr Cr 2234422
    Net Profit Qtr Cr 766111055
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 259224
    Operating Expenses Annual Cr 199159
    Operating Profit Annual in Cr 5561
    Depreciation Cr 1010
    Interest Annual Cr 62
    Tax Annual Cr 1214
    Net Profit Annual Cr 3240
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 3316
    Cash from Investing Activity Annual Cr -72-111
    Cash from Financing Annual Activity Cr 4195
    Net Cash Flow Annual Cr 30
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 292268
    Fixed Assets Annual Cr 257166
    Total Non Current Assets Annual Cr 330258
    Total Current Assets Annual Cr 216166
    Total Assets Annual Cr 546424
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 344316
    ROE Annual % 1115
    ROCE Annual % 1216
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2430
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 70886775735156
    Operating Expenses Qtr Cr 57735656604346
    Operating Profit Qtr Cr 1314121913710
    Depreciation Qtr Cr 4555555
    Interest Qtr Cr 8314222
    Tax Qtr Cr 3234422
    Net Profit Qtr Cr 46511748
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 281249
    Operating Expenses Annual Cr 215175
    Operating Profit Annual in Cr 5160
    Depreciation Cr 2117
    Interest Annual Cr 94
    Tax Annual Cr 1214
    Net Profit Annual Cr 2739
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 249
    Cash from Investing Activity Annual Cr -77-117
    Cash from Financing Annual Activity Cr 42112
    Net Cash Flow Annual Cr -124
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 280260
    Fixed Assets Annual Cr 408319
    Total Non Current Assets Annual Cr 442367
    Total Current Assets Annual Cr 228195
    Total Assets Annual Cr 670562
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 339314
    ROE Annual % 1015
    ROCE Annual % 912
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2531
    Invest in Hester Biosciences

    Hester Biosciences Technicals

    EMA & SMA

    Current Price
    ₹1523.65
    -12.6 (-0.82%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹1578.15
    • 50 Day
    • ₹1627.13
    • 100 Day
    • ₹1664.11
    • 200 Day
    • ₹1728.6
    • 20 Day
    • ₹1590.35
    • 50 Day
    • ₹1640.62
    • 100 Day
    • ₹1682.44
    • 200 Day
    • ₹1702.38

    Hester Biosciences Resistance and Support

    PIVOT
    ₹1527.25
    Resistance
    First Resistance ₹1536.4
    Second Resistance ₹1549.15
    Third Resistance ₹1558.3
    RSI 32.04
    MFI 25.55
    MACD Single Line -32.11
    MACD -35.97
    Support
    First Resistance ₹1514.5
    Second Resistance ₹1505.35
    Third Resistance ₹1492.6

    Hester Biosciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 3,387 264,897 78.21
    Week 2,877 201,983 70.2
    1 Month 4,421 300,022 67.86
    6 Month 6,036 389,431 64.52

    Hester Biosciences Result Highlights

    Hester Biosciences Synopsis

    NSE-Medical-Ethical Drugs

    Hester Biosciences L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 254.00 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2023. Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333.
    Market Cap 1,296
    Sales 278
    Shares in Float 0.39
    No of funds 15
    Yield 0.53
    Book Value 4.43
    U/D Vol ratio 0.5
    LTDebt / Equity 29
    Alpha -0.11
    Beta 0.64

    Hester Biosciences

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 53.73%53.73%53.73%53.73%
    Mutual Funds 0.03%
    Foreign Portfolio Investors 0.42%0.45%0.45%0.45%
    Individual Investors 33.19%33.36%33.02%32.96%
    Others 12.66%12.46%12.8%12.83%

    Hester Biosciences Management

    Name Designation
    Dr. Bhupendra Gandhi Chairman
    Mr. Rajiv Gandhi Managing Director & CEO
    Ms. Priya Gandhi Executive Director
    Mr. Ravin Gandhi Director
    Mr. Sanjiv Gandhi Director
    Mr. Ashok Bhadakal Independent Director
    Ms. Sandhya Patel Independent Director
    Mr. Ameet Desai Independent Director
    Ms. Nina Gandhi Alternate Director

    Hester Biosciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Hester Biosciences Corporate Action

    Date Purpose Remarks
    2023-11-07 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-17 Audited Results & Final Dividend
    2023-01-31 Quarterly Results
    2022-11-04 Quarterly Results

    Hester Biosciences MF Shareholding

    Name Amount(cr)
    Motilal Oswal S&P BSE Healthcare ETF 8

    Hester Biosciences FAQs

    What is Share Price of Hester Biosciences ?

    Hester Biosciences share price is ₹1523 As on 29 November, 2023 | 02:08

    What is the Market Cap of Hester Biosciences ?

    The Market Cap of Hester Biosciences is ₹1296.2 Cr As on 29 November, 2023 | 02:08

    What is the P/E ratio of Hester Biosciences ?

    The P/E ratio of Hester Biosciences is 50.5 As on 29 November, 2023 | 02:08

    What is the PB ratio of Hester Biosciences ?

    The PB ratio of Hester Biosciences is 4.5 As on 29 November, 2023 | 02:08

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.